Pila Pharma: Interview with analyst Filip Einarsson (video)
Redeye recently initiated coverage of Pila Pharma. Redeye Research Analyst Filip Einarsson walks us through the case, potential risks and what to expect in the future.
RR
Redaktionen Redeye
Disclosures and disclaimers